A significant block deal was executed in Apollo Hospitals Enterprises Limited as Managing Director and promoter Suneeta Reddy sold a 1.32% stake worth ₹1,489 crore. The transaction comes amid the healthcare major’s strong financial performance and ambitious expansion strategy.
Apollo Hospitals Enterprises Limited, headquartered in Chennai, Tamil Nadu, is a leading player in India’s private healthcare sector with a presence across hospitals, pharmacies, diagnostic centers, and digital health platforms.
On August 22, 2025, the company’s shares witnessed pressure in morning trade after a large block deal involving nearly 18.97 lakh shares, valued at ₹1,489 crore. The transaction was executed at a floor price of ₹7,850 per share, slightly below the previous close of ₹7,926 on the National Stock Exchange (NSE).
The seller in the transaction was Suneeta Reddy, Managing Director and promoter of Apollo Hospitals. Before the sale, Reddy held a 3.36% stake in the company as of June 2025. Following this divestment, her holding is expected to reduce to 2.11%.
Reddy, who has been associated with Apollo since 1989, remains a key part of the founding family and has played a vital role in the group’s evolution into one of India’s largest healthcare providers.
Strong Financial Performance
The stake sale comes on the back of a robust first quarter. For Q1 FY25, Apollo reported a 42% year-on-year rise in consolidated net profit, reaching ₹433 crore, compared to ₹305 crore in the same quarter last year. Total revenue increased by 15% to ₹5,842 crore, supported by growth across hospital operations, pharmacies, and digital health businesses.
EBITDA rose 26% to ₹851.5 crore, with operating margins improving to 14.6% from 13.3%, reflecting operational efficiency and higher contributions from core segments.
Also Read: Apollo Hospitals’ Q1 Net Profit Soars 42% on Strong Healthcare and Digital Growth
Expansion Strategy
Apollo Hospitals has outlined a ₹7,600 crore investment plan over the next five years aimed at expanding its hospital network. The company intends to add over 4,300 new beds across key cities such as Bengaluru and Hyderabad, further strengthening its leadership in India’s healthcare sector.
In addition to physical infrastructure, Apollo continues to enhance its preventive and digital healthcare portfolio. Recent initiatives include Apollo Zen, an AI-driven preventive health program, and OraLife, a technology-enabled initiative for early detection of oral cancer.
Market Outlook
Despite the block transaction, Apollo Hospitals’ stock closed the day higher at ₹7,926, up by 0.55%, reflecting investor confidence in the company’s long-term growth plans. The stock has also delivered a gain of over 13% in the past three months, underscoring its strong market momentum.
Apollo’s consistent earnings growth, planned capacity additions, and focus on technology-driven healthcare solutions position it strongly for sustained performance in the Indian healthcare market.
READ MORE ON